Zobrazeno 1 - 10
of 18
pro vyhledávání: '"D. Ruci"'
Publikováno v:
Annals of the Rheumatic Diseases. 80:1360.1-1360
Background:The COVID-19 global pandemic has had a great impact on world population due to morbidity, mortality and restriction measures in order to stop the progression of COVID-19.Patients with rheumatic and musculoskeletic diseases, and especially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea14992e55842808a9137785e1808e27
https://doi.org/10.1136/annrheumdis-2021-eular.576
https://doi.org/10.1136/annrheumdis-2021-eular.576
Publikováno v:
Annals of the Rheumatic Diseases. 80:1381.1-1381
Background:Because of the inflammation boosting cytokines, Coronavirus disease 2019 (COVID-19) has demonstrated thrombotic consequences that have increased its morbidity and mortality. There is evidence that mechanisms that contribute in thrombosis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7150a81ecc3e8fcf8103c9cf081151b1
https://doi.org/10.1136/annrheumdis-2021-eular.3521
https://doi.org/10.1136/annrheumdis-2021-eular.3521
Autor:
M. Jordhani, D. Ruci
Publikováno v:
Annals of the Rheumatic Diseases. 79:1508.3-1508
Background:Antiphospholipid Syndrome (APS) is an autoimmune disorder characterized by venous/arterial thrombotic events and pregnancy morbidity in presence of pathogenic autoantibodies known as antiphospholipid antibodies (APL). APS is often associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7040ab7a6ebae72060c657c13d2c89c6
https://doi.org/10.1136/annrheumdis-2020-eular.776
https://doi.org/10.1136/annrheumdis-2020-eular.776
Publikováno v:
FRIDAY, 15 JUNE 2018.
Background Antiphospholipid syndrome (APS) is a known cause of thrombotic disorders, including Acute Myocardial Infarction (AMI). Although the incidence of APS in AMI patients it’s not known, it can be an important cause of myocardial infarction es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e3ffbaeb7e7674625807850e4ee843c
https://doi.org/10.1136/annrheumdis-2018-eular.7227
https://doi.org/10.1136/annrheumdis-2018-eular.7227
Publikováno v:
Poster session 7: New drugs and trageted therapy.
Introduction Haematological involvement in Systemic Lupus Erythematosus (SLE) is common in patients with SLE. On the other hand, one of the most important variables that helps in disease activity and severity is complement serum level. Objectives The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfed47911e18afdbb8c6d65bdf850149
https://doi.org/10.1136/lupus-2018-abstract.191
https://doi.org/10.1136/lupus-2018-abstract.191
Publikováno v:
International journal of oral and maxillofacial surgery. 40(7)
The aim of the present study was to estimate the prevalence of temporomandibular joint (TMJ) symptoms and clinical findings in Albanian patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. The authors examined 124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46adfbf1e7698e5546e98668d0949360
https://pubmed.ncbi.nlm.nih.gov/21459556
https://pubmed.ncbi.nlm.nih.gov/21459556